Pfizer and BioNTech’s COVID-19-flu Combination Vaccine Shows Mixed Results in Phase 3 Trial
In a recent Phase 3 trial, Pfizer and BioNTech's COVID-19-influenza vaccine candidate demonstrated comparable responses to the companies' existing...
COVID-19-flu vaccine